Ockham Oncology’s CSO highlights global strength of fully integrated company.




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Ockham Oncology’s CSO highlights global strength of fully integrated company.
Released on: July 26, 2013. © PharmaTelevision Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Ockham Oncology’s Chief Scientific Officer Clare Wareing, PhD recounts the companies history and emphasizes complementary strengths that add value following the combination of Ockham Oncology and Nexus Oncology.
  • Summary
  • Transcript
  • Participants
  • Company
Ockham Oncology’s Chief Scientific Officer Clare Wareing, PhD recounts the companies history and emphasizes complementary strengths that add value following the combination of Ockham Oncology and Nexus Oncology.
Ockham Oncology’s Chief Scientific Officer Clare Wareing, PhD recounts the companies history and emphasizes complementary strengths that add value following the combination of Ockham Oncology and Nexus Oncology.
Clare Wareing
Ockham Oncology
Ockham Oncology
At Ockham Oncology, we are committed to delivering global clinical development services in a complex and constantly evolving cancer research environment. Our experience and oncology expertise allows us to deliver solutions specific to the challenges associated with clinical trials. We are a team of passionate professionals helping our clients develop new therapies to improve the quality of life for cancer patients. At Ockham we are driven by outcome, yet defined by expertise.